Literature DB >> 10320053

Molecular mechanisms of insulin action in normal and insulin-resistant states.

Y Le Marchand-Brustel1.   

Abstract

Insulin resistance is central to the pathophysiology of type 2 diabetes. It has been known for some time that down-regulation and reduced kinase activity of the insulin receptor play a role in insulin resistance; however, it has recently emerged that defects in the intracellular responses to insulin are also very important. We studied the molecular basis of insulin resistance in mice in which injection with gold thioglucose led to the development of hyperphagia, obesity and insulin resistance over a 4-month period. We found that the insulin-stimulated activation of MAP kinase was defective in obese, insulin-resistant mice. Similarly, we investigated insulin-stimulated PI3-kinase activation in the isolated soleus muscle of lean and obese mice, and found a marked reduction in the PI3-kinase activation of obese animals. The magnitude of the effect was greater than the reduction in insulin receptor activation, suggesting that impairment of PI3-kinase activation is a very important element in the development of insulin resistance in obese mice. In keeping with this, we found that the defect in PI3-kinase activation developed in young obese mice before the emergence of overt insulin resistance. We investigated different mechanisms by which defects in the components of the insulin signalling cascade could emerge, including down-regulation and abnormal phosphorylation of signal molecules. In adipocytes from young obese mice in which insulin resistance had not yet developed, we found that there were already marked defects in IRS-1 tyrosine phosphorylation. Increased IRS-1 phosphorylation on serine and threonine residues affects tyrosine phosphorylation. Such a process could contribute to the defective IRS-1 tyrosine phosphorylation in insulin-resistant animals. We found that brief exposure of 3T3-L1 adipocytes to platelet-derived growth factor led to IRS-1 serine/threonine phosphorylation through a PI3-kinase-dependent pathway, and that this prevented phosphorylation of the tyrosine residues of IRS-1. Such a mechanism, induced by growth factors, TNF-alpha or some other agent, may play an important role in the development of insulin resistance in obese mice.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10320053     DOI: 10.1055/s-0029-1212087

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  6 in total

1.  Prevention of fat-induced insulin resistance by salicylate.

Authors:  J K Kim; Y J Kim; J J Fillmore; Y Chen; I Moore; J Lee; M Yuan; Z W Li; M Karin; P Perret; S E Shoelson; G I Shulman
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

2.  A role for heterotrimeric GTP-binding proteins and ERK1/2 in insulin-mediated, nitric-oxide-dependent, cyclic GMP production in human umbilical vein endothelial cells.

Authors:  O Konopatskaya; A C Shore; J E Tooke; J L Whatmore
Journal:  Diabetologia       Date:  2005-03-01       Impact factor: 10.122

3.  Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle.

Authors:  J K Kim; M D Michael; S F Previs; O D Peroni; F Mauvais-Jarvis; S Neschen; B B Kahn; C R Kahn; G I Shulman
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

4.  Effect of vanadate on gene expression of the insulin signaling pathway in skeletal muscle of streptozotocin-induced diabetic rats.

Authors:  Dan Wei; Ming Li; Wenjun Ding
Journal:  J Biol Inorg Chem       Date:  2007-09-14       Impact factor: 3.358

5.  The association study of high-sensitivity C-reactive protein, pentraxin 3, nitrotyrosine, and insulin dose in patients with insulin-treated type 2 diabetes mellitus.

Authors:  Cornelia Bala; Adriana Rusu; Dana Mihaela Ciobanu; Anca Elena Craciun; Gabriela Roman
Journal:  Ther Clin Risk Manag       Date:  2018-05-28       Impact factor: 2.423

Review 6.  Current status and patent prospective of animal models in diabetic research.

Authors:  Radhey S Dhuria; Gurpreet Singh; Anudeep Kaur; Ramandeep Kaur; Tanurajvir Kaur
Journal:  Adv Biomed Res       Date:  2015-05-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.